Skip to main content
Caplight Logo









Bioeast Biotech

Bioeast Biotech

Private
HangzhouHealthcare & Life Scienceshttps://www.bioeast.com/

Last Round

Series A

Extension

May 10, 2022

Total Funding Raised

$37.8M

Company Overview

Bioeast Biotech is a biotechnology company that provides core raw materials and overall solutions for the in-vitro diagnostic, life science, and biomedical industries.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Advanced Materials, Medical Devices

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting

AI Layer

Non-AI

Keywords

IVD raw materialsantigensantibodiesmagnetic beadsin-vitro diagnosticsIVDassay componentsnano microspheresdiagnostic reagentslife science raw materialsimmunoassay reagentsenzymesCLIAELISAlateral flow assaymolecular diagnosticsISO 13485

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Bioeast Biotech Comparables

Compare Bioeast Biotech with similar companies based on industry and business-model similarity.

Bioeast Biotech comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Suzhou VDO Biotech Co., Ltd.
83%
Medix Biochemica
81%
Shenzhen Mindray Bio-Medical Electronics Co., Ltd.
77%

Bioeast Biotech Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series A ExtensionMay 10, 2022
Series ASep 1, 2021

Bioeast Biotech Investors

Notable investors and investment history

Bioeast Biotech investors
InvestorRounds
Co-Win VenturesSeries A, Angel
YuanBio Venture CapitalSeries A, Angel
LYFE CapitalSeries A Extension
Grand Mount CapitalSeries A
华创资本Series A

Market signals

Structured signals derived from secondary market and firmographic data.

  • Dec 12, 2024

    Grew 20% QoQ from 15 to 18 employees.

  • Oct 23, 2024

    Grew 20% QoQ, from 15 to 18 employees.

Bioeast Biotech Filings

SEC and related filings with document metadata.

Data table
TypedDateAmount OfferedAmount SoldFillingPagesDownload
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation
Sign Up to view
Mock Valuation

Bioeast Biotech Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Bioeast Biotech's valuation, stock price, and market status.

Firmographic Details

HeadquartersHangzhou
Employee Range20
Year Founded2018
Last FundingMay 10, 2022

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?